| Fighting COVID-19 at the expense of malaria in Africa: The Consequences and Policy Options | Sub-Saharan Africa | General population | Opinion paper | Supply chain disruptions; financial shortages; problems for HCWs; changed health-seeking behaviour; simplified modelling studies, real outcome could be worse |
| Digitalized mass distribution campaign of ITNs in the particular context of Covid-19 pandemic in Benin: Challenges and lessons learned | Benin | General population | Country report | Benin: successful ITN and IRS campaigns, adapted to COVID-19 hygiene measures |
| Malaria and COVID-19: Commonalities, intersections and implications for sustaining malaria control | Africa | General population | Opinion paper | COVID-19 and malaria are both related to low socio-economic status; health system and diagnostical challenges; changed health seeking; lack of reliable data due to limited reporting |
| What does the COVID-19 pandemic mean for HIV, tuberculosis and malaria control? | Africa | General population | Report | Clinical and socio-economic aspects; changed health-seeking behaviour |
| The potential impact of the COVID-19 pandemic on HIV, tuberculosis and malaria control in Africa: A systematic review of modelling studies and population surveys | Africa | General population | Review | Malaria programme and antenatal clinic disruptions; antenatal care avoidance; increased costs for malaria services |
| Co-morbidities and the COVID-19 pandemic dynamics in Africa | Sub-Saharan Africa | General population | Review | Clinical aspects e.g., overlapping age groups, common symptoms; malaria health service disruptions |
| Effects of disruption from COVID-19 on anti-malarial strategies | Sub-Saharan Africa | General population | Opinion paper | Health system challenges; COVID-19 myths and misinformation affect malaria (reduced ITN usage, increased anti-malarial uptake) |
Baral et al. [ 56]—pre-print | Competing health risks associated with the COVID-19 pandemic and response: A scoping review | General and Africa | General population | Review | 73% disruptions among malaria programmes; 62% decrease of malaria diagnoses; delays in malaria surveillance |
Bell and Hansen, [ 24]—pre-print | Relative burdens of the COVID-19, malaria, tuberculosis and HIV/AIDS epidemics in sub-Saharan Africa | Sub-Saharan Africa | General population | Modelling study | Low direct COVID-19 impacts in SSA but high indirect impacts on other diseases such as malaria |
| Predicting the impact of COVID-19 and the potential impact of the Public Health Response on Disease Burden in Uganda | Uganda | General population | Modelling study | Reduction of malaria cases, admissions, deaths in Uganda |
| Emergence of undetectable malaria parasites: A threat under the radar amid the COVID-19 pandemic? | General and Africa specific | General population | Opinion paper | Diagnostic challenges for malaria due to mutated parasites; clinical challenges and treatment problems |
| Implementing malaria control in South Africa, Eswatini and southern Mozambique during the COVID-19 pandemic | South Africa, Eswatini, southern Mozambique | General population | Review | Disruptions of malaria programmes; diagnostic, health system and socio-economic challenges |
| Child healthcare and immunizations in sub-Saharan Africa during the COVID-19 pandemic | Sierra Leone | Children under the age of 5 years | Country report | Reduction in malaria diagnoses (25–40%); no increases in malaria deaths |
| Management of malaria in children under 5 years old during COVID-19 pandemic in Sierra Leone: A lesson learned? | Sierra Leone | Children under 5 years | Country report | Changes in malaria diagnoses at health facilities in context of the lockdown; community education campaign in Sierra Leone; difficult data collection |
Burt et al. [ 62]—pre-print | Indirect effects of COVID-19 on maternal, neonatal, child, sexual and reproductive health services in Kampala, Uganda | Uganda | Mothers and newborns | Country report | Greatest impacts from delayed health seeking, no public transport, HCWs disruptions; closures of health facilities for outpatients; decreased antenatal care impacts IPTp; visits for malaria in children decreased by 54% |
Chanda-Kapata et al. [ 26] | COVID-19 and malaria: A symptom screening challenge for malaria-endemic countries | Africa | General population | Opinion paper | Health system disruptions; clinical aspects; importance of parallel testing; malaria commodities supply disruptions |
| An update on malaria trends in Zambia (2019 to 2020); A descriptive study | Zambia | General population | Country report | Increased malaria testing and cases |
| Things must not fall apart: The ripple effects of the COVID-19 pandemic on children in sub-Saharan Africa | Sub-Saharan Africa | Children aged 0 to 19 years | Review | Malaria elimination is threatened by COVID-19 |
| Malaria and COVID-19: Common and different findings | General and SSA-specific | General population | Opinion paper | Changed health-seeking behaviour disproportionately affects children; health system challenges; clinical aspects, co-infections |
| COVID-19 during malaria transmission season in Africa and why we should be prepared: An example from Senegal | Senegal | General population | Opinion paper | Changed health-seeking behaviour; clinical aspects; COVID-19 and malaria management challenges |
Elliot Mbunge et al. [ 50]—pre-print | Impact of COVID-19 on malaria elimination: Juxtaposing indoor residual spraying and mobile phones in Buhera Rural District, Zimbabwe | Zimbabwe | General population | Country report | IRS delays in 2020; increase in malaria cases (2981 in 2020, 1376 in 2019); disruptions of health services; anti-malarial resistance problems; challenges for HCWs |
Emmanuel Awucha et al. [ 52] | Impact of the COVID-19 pandemic on consumers’ access to essential medicines in Nigeria | Nigeria | General population | Country report | Increase in alternative medicines uptake (10%) and prizes for anti-malarials; supply chain disruptions; 74% reported less income during the pandemic; LMICs strongly depend on importations |
| Malaria incidence and mortality in Zimbabwe during the COVID-19 pandemic: Analysis of routine surveillance data | Zimbabwe | General population | Country report | 16% more malaria cases and 28% more malaria deaths than expected in 2020, probably following several malaria outbreaks |
| Malaria vector control in sub-Saharan Africa in the time of COVID-19: No room for complacency | Sub-Saharan Africa | General population | Opinion paper | Clinical and diagnostical aspects; impacts on vector control measures; malaria campaign delays |
Hategeka et al. [ 63]—pre-print | Impact of the COVID-19 pandemic and response on the utilization of health services during the first wave in Kinshasa, the DRC | Democratic Republic of the Congo | General population | Country report | 20–90% reductions in health facility visits for malaria, depending whether the areas had lockdown or not |
| Malaria and COVID-19: Unmasking their ties | General and Africa specific | General population | Review | Hypothesis of causal link between antimalarials usage and low COVID-19 incidence; clinical aspects; challenges for malaria programmes |
| Genomic-informed pathogen surveillance in Africa: Opportunities and challenges | Africa | General population | Opinion paper | Benefits for malaria from genomics-based surveillance strategy for COVID-19 |
| Re-reading ACT, BCG, and low COVID-19 in Africa | Africa | General population | Opinion paper | Hypothesis: low COVID-19 incidence due to anti-malarial usage and malaria antibodies |
Kusotera and Nhengu, [ 27] | Coronavirus-19 and malaria: The great mimics | Zimbabwe | General population | Country report | Concerns of false positive SARS-CoV-2 Ag-RDTs in malaria infected persons; increase in malaria cases in 2020 (44.7%); overlapping clinical aspects; health system challenges |
| COVID-19 and malaria in sub-Saharan Africa: Holistic diagnostic approaches may promote effective clinical case management | Sub-Saharan Africa | General population | Review | Importance of parallel testing for SARS-CoV-2 and malaria; clinical and health system difficulties |
Menelas and Sabin [ 71]—pre-print | Malaria or COVID-19? A case report highlighting a diagnostic challenge in Africa | Rwanda | 40 years old woman | Case report | Difficult diagnosis of malaria-COVID-19 co-infection |
| Mass intake of hydroxychloroquine or chloroquine in the present context of the Covid-19 outbreak: Possible consequences in endemic malaria settings | General and Africa | General population | Opinion paper | Antimalarials uptake for COVID-19 affect malaria and resistance development |
| Global health security requires endemic disease eradication | General and SSA | General population | Opinion paper | Over 90% of malaria campaigns undertaken in 2020; increase of health inequities; benefits of malaria eradication for COVID-19 |
| Pausing the fight against malaria to combat the COVID-19 pandemic in Africa: Is the Future of Malaria Bleak? | sub-Saharan Africa | General population | Opinion paper | Anti-malarial resistance; RDTs supply shortages; increases of malaria cases and deaths in Zimbabwe and Cameroon; diagnostic challenges; changed health-seeking and effects on children |
US President’s malaria initiative [ 86] | 15 years of fighting malaria and saving lives, Annual Report to Congress, April 2021 | Sub-Saharan Africa and Southeast Asia | General population | Report | Seasonal malaria chemoprevention for children in Sahel with minimal delays; community approach for malaria prevention; difficult health care access (nearly 50% of the participants) |
| COVID-19 Mitigation steps provide a blueprint for malaria control and elimination | General and Africa | General population | Opinion paper | COVID-19 control lessons important for malaria management |
| Identifying and combating the impacts of COVID-19 on malaria | General and Africa specific | General population | Opinion paper | Treatment disruptions; socio-economic aspects; challenges for HCWs; malaria product disruptions; health system challenges, malaria surveillance problems |
| COVID-19: Shining the light on Africa | Sub-Saharan Africa | General population | Opinion paper | Financial aspects; anti-malarial shortages |
Sherrard-Smith et al. [ 23] | The potential public health consequences of COVID-19 on malaria in Africa | Sub-Saharan Africa | General population | Modelling study | Malaria deaths in 2020 could double; impact of ITN and anti-malarial disruptions; benefits of seasonal malaria chemoprevention, mass drug administration, presumptive malaria treatment |
| Accessing the syndemic of COVID-19 and malaria intervention in Africa | Sub-Saharan Africa (Ethiopia, Nigeria, Tanzania, Zambia) | General population | Modelling study | Greatest impact on malaria health services if COVID-19 waves and main malaria season overlap |
| World Malaria Day 2021: Commemorating 15 Years of contribution by the US President’s Malaria Initiative | General and Africa | General population | Opinion paper | Nearly all malaria campaigns undertaken despite the pandemic; disruptions of malaria testing, and treatment; excess malaria deaths could exceed COVID-19 deaths in some regions |
The alliance for malaria prevention [ 58] | 2020 Annual Report | General and Africa | General population | Report | 74% of planned ITNs distributed |
The Global Fund, 2021 [ 32] | The impact of COVID-19 on HIV, tuberculosis and malaria services and systems for health: A snapshot from 502 health facilities across Africa and Asia | Africa and Asia | General population | Report | Up to 115 million people in extreme poverty; fear of COVID-19 infection in health facilities as main reason for reduced outpatient visits; malaria diagnosis and treatment reduced by 17 and 15%, respectively; anti-malarials stock-outs (21% of all health facilities), lack of PPE (64%), deficits in COVID-19 testing capacities, lack of malaria treatments (40%); about 75% of malaria programmes reported disruptions; large financial resources needed |
| COVID-19 and syndemic challenges in ‘Battling the Big Three’: HIV, TB and malaria | General and Africa | General population | Review | Increased malaria cases in many countries, suspended vector control activities |
| Preparedness is essential for malaria-endemic regions during the COVID-19 pandemic | Africa | General population | Opinion paper | Measures to reduce malaria support the COVID-19 response; health system challenges |
| Indirect effects of the COVID-19 pandemic on malaria intervention coverage, morbidity, and mortality in Africa: A geospatial modelling analysis | Africa | General population | Modelling study | Anti-malarial disruptions with greater impact on malaria incidence and deaths than ITNs; great variability between countries |
| The potential impact of health service disruptions on the burden of malaria: A modelling analysis for countries in sub-Saharan Africa | Sub-Saharan Africa | General population | Modelling study | Importance of ITNs; impacts on malaria burden following ITN and anti-malarials shortages; worst case scenario: 769,000 deaths (743,000 in SSA), 70% in children under 5 years |
| Tailoring malaria interventions in the COVID-19 response | General and Africa | General population | Policy guideline | Mass drug administration or presumptive treatment of malaria; adaptation of malaria interventions |
| World malaria report 2020: 20 years of global progress and challenges, Chapter 10 | General and SSA specific | General population | Report and modelling study | Disruptions of malaria health services; delays of malaria programmes; changed health-seeking; adaptation of malaria programmes and guidelines; malaria product shortages; 100,000 additional deaths if 50% anti-malarials disruptions |
| The impact of COVID-19 pandemic on malaria elimination | General and Africa | General population | Review | COVID-19 challenges Africa’s weak health system; increase in malaria cases; indirect social effects, malaria outbreak in Zimbabwe during the lockdown; clinical challenges |